FIFTH INTERNATIONAL SYMPOSIUM ON CANCER RESEARCH AND AIDS. JANUARY 11-13, 1989, VENICE, ITALY NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


FIFTH INTERNATIONAL SYMPOSIUM ON CANCER RESEARCH AND AIDS. JANUARY 11-13, 1989, VENICE, ITALY

Fifth International Symposium on Cancer Research and AIDS. January 11-13, 1989, Venice, Italy, French Association for Cancer Research, European School of Oncology, National Institutes of Health, 46 p., 1989.. Unique Identifier : AIDSLINE ICDB/90660290
Anonymous; No affiliation given

Abstract: The proceedings of the Fifth International Symposium on Cancer Research and AIDS, held January 11-13, 1989, in Venice, Italy, contains abstracts of papers on the following topics from the six sessions. (1) Tumor-regulating genes and their products: oncogenes as probes for cellular signal processes--the family of ETS genes, altered regulation of receptor-associated tyrosine kinases in human tumors, transcription factors and transformation of hematopoietic cells, expression of oncogenes as a possible prognostic factor in human cancer, role of cellular interactions and cytokine production in EBV-associated nasopharyngeal carcinoma, bovine leukemia virus induction of a dramatic expansion of the CD5 B-cell compartment, and HIV and HBV diagnosis through polymerase chain reaction. (2) Laser--physical approaches to cancer treatment: physical aspects of tumor diagnosis and therapy with laser and hematoporphyrin, lasers plus interstitial hyperthermia or photodynamic therapy for local destruction of tumors, microsurgery by CO2 laser in early stage of vocal cord cancer, photodynamic therapy of superficial tumors of skin and head and neck, endoscopic neodymium-YAG laser for premalignant and malignant lesions of the GI tract, and laser oncologic abdominorectal surgery. (3) Advances in tumor immunology: usefulness of monoclonal antibodies in oncology; hormone precursors as tumor-associated markers; immunologic control of leukemias after bone marrow transplantation (BMT); Fc receptors, immunoglobulin-binding factors, and lymphoproliferative disorders; lymphocyte response to autologous human malignant melanoma; treatment of metastatic renal cell carcinoma with LANAK cells and interleukin 1; and immunotherapy of cancer using tumor-infiltrating lymphocytes. (4) International perspectives on AIDS: long-range perspectives on the HIV epidemic in the US, site-directed mutagenesis of HIV-1 gag protein, human retroviruses and the AIDS virus, interactions of CD4 and gp 120, characterization of HIV-1 gene products, neoplastic complications of AIDS, and prototype of candidate vaccine against AIDS. (5) Advances in clinical oncology: a new syndrome combining proliferative mastosis, uterine fibroids, ductal breast cancer, and familial breast cancer; testicular cancer--empirical cure, biologic implications; dose-effect relationship with BMTs in lymphomas and solid tumors; effect of granulocyte-macrophage colony-stimulating factor on neutropenia induced by chemotherapy; and preoperative chemotherapy and salvage operations for osteogenic sarcomas. (6) Public health policy and preventable cancers: in search of a smoke-free society--government and the private sector and NCI's approach, passive smoking and lung and other cancers, dietary fat and cancer prevention, and setting up an epidemiological register and a multidisciplinary screening center in France.
Keywords: Acquired Immunodeficiency Syndrome/GENETICS/*THERAPY Animal Gene Expression Regulation, Neoplastic *Gene Expression Regulation, Viral Human HIV/*GENETICS Neoplasms/GENETICS/*THERAPY MONOGRAPHKWDacquiredimmunodeficiencysyndrome/genetics/KWDtherapyanimalgeneexpressionregulation,neoplasticKWDgeneexpressionregulation,viralhumanhiv/KWDgeneticsneoplasms/genetics/KWDtherapymonograph
900530
M9051016

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .